论文部分内容阅读
目的 评价康莱特注射液治疗 31例晚期肺癌的临床效果。方法 康莱特注射液 2 0 0ml,每天一次静滴 ,连续 2 1天为一个疗程 ,间隔 3～ 5天 ,进行下一疗程 ,至少两疗程。结果 完全缓解 (CR) 1例 ,部分缓解 (PR) 9例 ,稳定 (NC) 15例 ,进展 (PD) 6例。多数病人治疗后精神、食欲、睡眠明显改善 ,疼痛减轻 ,无化疗的胃肠道反应及骨髓抑制 ,不良反应轻微。结论 康莱特注射液对晚期肺癌有一定疗效 ,能提高患者的生活质量。
Objective To evaluate the clinical effect of Kanglaite injection in the treatment of 31 patients with advanced lung cancer. Methods Kanglaite injection 200ml, once daily intravenous infusion, for 21 days as a course of treatment, interval 3 to 5 days, for the next course of treatment, at least two courses. Results There were one case of complete remission (CR), partial remission (PR) in 9 cases, stable (NC) in 15 cases, and progression (PD) in 6 cases. Most patients had improved mental, appetite and sleep after treatment, pain relief, no gastrointestinal reactions and bone marrow suppression with chemotherapy, and mild adverse reactions. Conclusion KLT has a certain effect on advanced lung cancer and can improve the quality of life of patients.